PathoGenesis Corp Q1 loss widens . Consolidated Statements of Operations ( Dollars in thousands , except per share data ) Three Months Ended 3 / 31 / 97 3 / 31 / 96Revenues : Grants and royalties $ 86 $ - - - Operating expenses : Research and development 5 , 823 4 , 491 General and administrative 1 , 340 833 Total operating expenses 7 , 163 5 , 324 Operating income ( loss ) ( 7 , 077 ) ( 5 , 324 ) Investment income , net 851 534 Net loss ( 6 , 226 ) ( 4 , 790 ) Net loss per common share ( 0 . 43 ) ( 0 . 44 ) Weighted average common shares outstanding 14 , 383 , 942 10 , 874 , 857 Balance Sheet Highlights March 31 , ( in thousands ) 1997 1996Cash , cash equivalents and investment securities $ 107 , 933 $ 32 , 539 Total current assets 108 , 885 33 , 339 Total assets 117 , 595 41 , 041 Total current liabilities 3 , 586 2 , 535 Long - term liability 25 319 Total stockholders ' equity 113 , 984 38 , 186 
